NANJING, China, May 28, 2026 — Yaohai Bio-Pharma congratulates its strategic partner, Beijing Northland Biotechnology Co., Ltd. (“Northland Bio”), on the NMPA approval of Donaperminogene
Yaohai Bio-Pharma will participate in Swiss Biotech Day 2026, one of Europe’s most influential biotechnology events. The conference will take place on May 4–5, 2026,
Yaohai Bio-Pharma operates a cutting-edge microbial CRDMO platform built on E. coli and yeast expression systems. In addition, we offer one-stop microbial cell banking solutions
Yaohai Bio-Pharma has more than 15 years of experience in microbial cell line development and cell bank construction. Microbial cell line development and high-yield strain
